Retacrit
List of products in the National Drug Code with proprietary name retacrit. This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer (cancer that does not involve the bone marrow or blood cells). It may also be used in anemic patients to reduce the need for blood transfusions before certain planned surgeries that have a high risk of blood loss (usually given with an anticoagulant/"blood thinner" medication such as warfarin to lower the risk of serious blood clots). Epoetin alfa-epbx works by signaling the bone marrow to make more red blood cells. This medication is very similar to the natural substance in your body (erythropoietin) that prevents anemia.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
0069-1305 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1306 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1307 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1308 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1309 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1311 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1318 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
59353-002 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Vifor (international) Inc. | Human Prescription Drug |
59353-003 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Vifor (international) Inc. | Human Prescription Drug |
59353-004 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Vifor (international) Inc. | Human Prescription Drug |
59353-010 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Vifor (international) Inc. | Human Prescription Drug |
59353-120 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Vifor (international) Inc. | Human Prescription Drug |
59353-220 | Retacrit | Epoetin Alfa-epbx | Injection, Solution | Intravenous; Subcutaneous | Vifor (international) Inc. | Human Prescription Drug |